Table 3

Overall survival according to PDGFRα and PDGFRβ mutational status
Mutational status Patients N (%) Overall survival
Median (months) % at 5y HR P
PDGFR-A13
  · WT (AA) 60 (82%) 37.1 14% 0.96 0.934
  · SNP (AG) 13 (18%) 21.7 41%
PDGFR-B19
  · WT (AA) 33 (42%) NR 51% 1.93 0.073
  · SNP (AG,GG) 45 (58%) 37.1 17%

WT: wild type; SNP: single nucleotide polymorphism; N: number; 5y: 5 years; HR: hazard ratio; NR: not reached.

Estevez-Garcia et al.

Estevez-Garcia et al. BMC Cancer 2012 12:514   doi:10.1186/1471-2407-12-514

Open Data